⚠️ JAN 12 – FEB 6 CYBERATTACK: ALL ORDERS REFUNDED • DO NOT PURCHASE UNTIL FURTHER NOTICE • CONTACT support@anubis.estate FOR REFUND STATUS
Post-market surveillanceSmall Molecule

Compound 61539

Formula Pending

Molecular Mass
N/A
CAS Registry
AUTO-061539
Risk Class
MODERATE
Last Audit
Mar 30, 2108

Research Abstract

Small Molecule candidate engineered for cellular repair initiatives with automated dossier coverage.

Compound 61539 is a small molecule asset inside small molecule innovation track initiatives, optimized for cellular repair and tissue regeneration.

The dossier currently sits in post-market surveillance with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.

Supply records cite CAS AUTO-061539 with updates logged 2108-03-30.

Acquisition Protocol

Authorized research personnel may request deployment of this compound for laboratory analysis.

Primary Vectors

Cellular repairTissue regeneration

Nomenclature

CX-61539Small Molecule Program 61539

Reference Material

  1. [1] Anubis Compound Registry • CAS AUTO-061539
  2. [2] Operations Pulse • Small Molecule innovation track
  3. [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61539